Literature DB >> 26059865

Reliability of Calculated Low-Density Lipoprotein Cholesterol.

Jeffrey W Meeusen1, Christine L Snozek2, Nikola A Baumann3, Allan S Jaffe4, Amy K Saenger3.   

Abstract

Aggressive low-density lipoprotein cholesterol (LDL-C)-lowering strategies are recommended for prevention of cardiovascular events in high-risk populations. Guidelines recommend a 30% to 50% reduction in at-risk patients even when LDL-C concentrations are between 70 and 130 mg/dl (1.8 to 3.4 mmol/L). However, calculation of LDL-C by the Friedewald equation is the primary laboratory method for routine LDL-C measurement. We compared the accuracy and reproducibility of calculated LDL-C <130 mg/dl (3.4 mmol/L) to LDL-C measured by β quantification (considered the gold standard method) in 15,917 patients with fasting triglyceride concentrations <400 mg/dl (4.5 mmol/L). Both variation and bias of calculated LDL-C increased at lower values of measured LDL-C. The 95% confidence intervals for a calculated LDL-C of 70 mg/dl (1.8 mmol/L) and 30 mg/dl (0.8 mmol/L) were 60 to 86 mg/dl (1.6 to 2.2 mmol/L) and 24 to 60 mg/dl (0.6 to 1.6 mmol/L), respectively. Previous recommendations have emphasized the requirement for a fasting sample with triglycerides <400 mg/dl (4.5 mmol/L) to calculate LDL-C by the Friedewald equation. However, no recommendations have addressed the appropriate lower reportable limit for calculated LDL-C. In conclusion, calculated LDL-C <30 mg/dl (0.8 mmol/L) should not be reported because of significant deviation from the gold standard measured LDL-C results, and caution is advised when using calculated LDL-CF values <70 mg/dl (1.8 mmol/L) to make treatment decisions.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26059865     DOI: 10.1016/j.amjcard.2015.05.013

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  Lipid Biomarkers for Risk Assessment in Acute Coronary Syndromes.

Authors:  Jeffrey W Meeusen; Leslie J Donato; Allan S Jaffe
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

Review 2.  My Approach to the Patient With Familial Hypercholesterolemia.

Authors:  Maya S Safarova; Iftikhar J Kullo
Journal:  Mayo Clin Proc       Date:  2016-06       Impact factor: 7.616

3.  Determination of Fasting and Non-Fasting Cholesterol Levels of Low- and High-Density Lipoproteins with Homogenous Assays: A Promising Reliable Way to Assessment of Dyslipidemia.

Authors:  Hiroshi Yoshida
Journal:  J Atheroscler Thromb       Date:  2017-05-10       Impact factor: 4.928

4.  Accuracy of low-density lipoprotein cholesterol estimation at very low levels.

Authors:  Renato Quispe; Aditya Hendrani; Mohamed B Elshazly; Erin D Michos; John W McEvoy; Michael J Blaha; Maciej Banach; Krishnaji R Kulkarni; Peter P Toth; Josef Coresh; Roger S Blumenthal; Steven R Jones; Seth S Martin
Journal:  BMC Med       Date:  2017-04-20       Impact factor: 8.775

5.  Validity of a Novel Method for Estimating Low-Density Lipoprotein Cholesterol Levels in Cardiovascular Disease Patients Treated with Statins.

Authors:  Takeshi Sonoda; Takuro Takumi; Masaaki Miyata; Daisuke Kanda; Ippei Kosedo; Satoshi Yoshino; Mitsuru Ohishi
Journal:  J Atheroscler Thromb       Date:  2018-05-23       Impact factor: 4.928

6.  Association of baseline as well as change in lipid levels with the risk of cardiovascular diseases and all-cause deaths.

Authors:  Hsin-Yin Hsu; Ming-Chieh Tsai; Tzu-Lin Yeh; Le-Yin Hsu; Lee-Ching Hwang; Kuo-Liong Chien
Journal:  Sci Rep       Date:  2021-04-01       Impact factor: 4.379

7.  LDL-C calculated by Friedewald, Martin-Hopkins, or NIH equation 2 versus beta-quantification: pooled alirocumab trials.

Authors:  Henry N Ginsberg; Robert S Rosenson; G Kees Hovingh; Alexia Letierce; Rita Samuel; Yann Poulouin; Christopher P Cannon
Journal:  J Lipid Res       Date:  2021-11-11       Impact factor: 5.922

8.  Identification of Dysbetalipoproteinemia by an Enhanced Sampson-NIH Equation for Very Low-Density Lipoprotein-Cholesterol.

Authors:  Maureen Sampson; Anna Wolska; Jeff W Meeusen; Leslie J Donato; Allan S Jaffe; Alan T Remaley
Journal:  Front Genet       Date:  2022-07-14       Impact factor: 4.772

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.